IQVIA™ Pharma Deals: PharmaDeals Review: Table of Contents

<< Previous Issue

Oct 2002 (Vol: 2002, Issue: 29)

Next Issue >>

Download pdf of entire issue

Section: Company Profile
Innogenetics NV Published: 2 Oct-2002
By: Business Review Editor
Abstract Fulltext:
Section: Distribution & Marketing
Ferrer to Distribute AVAX Vaccine in Europe/Latin America Published: 2 Oct-2002
By: Business Review Editor
Abstract Fulltext:
Enzon to Acquire North American and Japanese Rights to Elan Drug Published: 2 Oct-2002
By: Business Review Editor
Abstract Fulltext:
Section: General
UK Oncology plc Published: 2 Oct-2002
By: Business Review Editor
Abstract
The Licensing of University Technologies Published: 2 Oct-2002
By: Business Review Editor
Abstract
Therapy Focus: Interferons Published: 2 Oct-2002
By: Business Review Editor
Abstract
Section: Licensing
KS Biomedix Secures European Deal Over TransMID™-R Published: 2 Oct-2002
By: Business Review Editor
Abstract Fulltext:
Eli Lilly Licenses Amylin Diabetes Treatment in US$325 M Deal Published: 2 Oct-2002
By: Business Review Editor
Abstract Fulltext:
Igeneon Licenses Cancer Vaccine from Novartis Published: 2 Oct-2002
By: Business Review Editor
Abstract Fulltext:
Access Oncology Licenses Zentaris’ Anticancer Compound Published: 2 Oct-2002
By: Business Review Editor
Abstract Fulltext:
Section: Mergers & Acquisitions
Adherex Technologies to Merge with Oxiquant Published: 2 Oct-2002
By: Business Review Editor
Abstract Fulltext:
GenStar Therapeutics and Vascular Genetics Announce Merger Published: 2 Oct-2002
By: Business Review Editor
Abstract Fulltext:
Section: Research & Development
Roche and Kosan to Co-develop Anticancer Drug Published: 2 Oct-2002
By: Business Review Editor
Abstract Fulltext:
Chiron to use Serenex’s Proteome Mining™ Technology Published: 2 Oct-2002
By: Business Review Editor
Abstract Fulltext:

Login

Username:

Password:

Keep me logged in